Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ACE2 anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement ACE2 dans WB, ELISA et FACS. Il présente une réactivité envers Humain et a été mentionné dans 4+ publications.
N° du produit ABIN1169449

Aperçu rapide pour ACE2 anticorps (ABIN1169449)

Antigène

Voir toutes ACE2 Anticorps
ACE2 (Angiotensin I Converting Enzyme 2 (ACE2))

Reactivité

  • 149
  • 53
  • 48
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 130
  • 29
  • 6
  • 2
  • 1
Souris

Clonalité

  • 117
  • 51
Monoclonal

Conjugué

  • 91
  • 17
  • 11
  • 8
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp ACE2 est non-conjugé

Application

  • 128
  • 72
  • 59
  • 42
  • 30
  • 18
  • 18
  • 17
  • 16
  • 11
  • 10
  • 6
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Flow Cytometry (FACS)

Clone

AC18F
  • Specificité

    Recognizes human ACE2.

     Réactivité croisée

    Humain

    Stérilité

    0.2 μm filtered

    Immunogène

    Recombinant human ACE2.

    Isotype

    IgG1
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives.

    Agent conservateur

    Without preservative

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Short Term Storage: +4°C
    Long Term Storage: -20°C
    Stable for at least 1 year after receipt when stored at -20°C.

    Date de péremption

    12 months
  • Chaouat, Achdout, Kol, Berhani, Roi, Vitner, Melamed, Politi, Zahavy, Brizic, Lenac Rovis, Alfi, Wolf, Jonjic, Israely, Mandelboim: "SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection." dans: PLoS pathogens, Vol. 17, Issue 12, pp. e1010175, (2022) (PubMed).

    Chaouat, Brizic, Kucan Brlic, Atari, Kliker, Alfi, Mandelboim, Wolf, Tafish, Kol, Jonjic, Mandelboim: "Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern." dans: iScience, Vol. 25, Issue 9, pp. 104935, (2022) (PubMed).

    Buchrieser, Dufloo, Hubert, Monel, Planas, Rajah, Planchais, Porrot, Guivel-Benhassine, Van der Werf, Casartelli, Mouquet, Bruel, Schwartz: "Syncytia formation by SARS-CoV-2-infected cells." dans: The EMBO journal, pp. e106267, (2020) (PubMed).

    Zulli, Rai, Buxton, Burrell, Hare: "Co-localization of angiotensin-converting enzyme 2-, octomer-4- and CD34-positive cells in rabbit atherosclerotic plaques." dans: Experimental physiology, Vol. 93, Issue 5, pp. 564-9, (2008) (PubMed).

  • Antigène

    ACE2 (Angiotensin I Converting Enzyme 2 (ACE2))

    Autre désignation

    ACE2

    Sujet

    ACE2 has direct effects on cardiac functions. It is expressed predominantly in vascular endothelial cells of the heart and kidney. ACE2 converts angiotensin I to angiotensin 1-9. ACE2 was also identified as a functional receptor for SARS coronavirus.

    UniProt

    Q9BYF1

    Pathways

    ACE Inhibitor Pathway, Peptide Hormone Metabolism, Regulation of Systemic Arterial Blood Pressure by Hormones, Feeding Behaviour
Vous êtes ici:
Blank Blank Blank Blank
Blank Blank Blank Blank
Chat with us!